Instem

Instem Cash Conversion

Delisted

The Cash Conversion Rate (OCF/Net Income) of Instem (INS.L) as of Nov 22, 2026 is 167.60 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 547.62 % — a change of -69.40% (lower).

Cash Conversion

167.60 %

YoY

-69.40%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Instem is 2022 167.60 % . Cash Conversion Rate (OCF/Net Income) of Instem was 2021 547.62 % . It decreases by -69.40% lower compared to the previous year.

The Instem Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2015
-581.40 GBP
Jan 1, 2016
12.26 GBP
Jan 1, 2017
217.19 GBP
Jan 1, 2018
149.66 GBP
Jan 1, 2019
-589.13 GBP
Jan 1, 2020
305.73 GBP
Jan 1, 2021
547.62 GBP
Jan 1, 2022
167.60 GBP
The Instem Cash Conversion history
YEARCash ConversionYoY
167.60 %-69.40%
547.62 %+79.12%
305.73 %-151.89%
-589.13 %-493.65%
149.66 %-31.09%
217.19 %+1,670.91%
12.26 %-102.11%
-581.40 %-281.69%
320.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instem Stock analysis

What does Instem do? Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instem stock

Cash Conversion Rate (OCF/Net Income) of Instem is 167.60 % in 2022.

Cash Conversion Rate (OCF/Net Income) of Instem changed from 547.62 % to 167.60 %, representing a -69.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Instem since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Instem with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Instem

All Key Metrics — Instem